University of Washington Medicine
Home
eFacts Micromedex MINDscape PubMed
Google Search HealthLinks MEDLINEplus Alpine email
Patient Safety Net UWMC Anticoagulation Services Clinical Toolkit UW Medicine Drug Formulary
Health Online UW Medicine Pharmacy Staff Site

Search:

Drug Therapy Topics

Drug Therapy Topics Newsletter Published monthly by authority of the UW Medicine Pharmacy and Therapeutics Committee, Drug Therapy Topics newsletter focuses on issues relating to drug prescribing at the University of Washington Medical Centers. Supplements broaden the focus of the newsletter by discussing contemporary issues in evolving drug therapies.


Drug Therapy Topics

There are 114 records.
Page: 1 | 2 | 3 | 4 | 5 | 6
Search
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Search Terms:    



Newsletter Supplement
81: Vol. 31 No. 1 (2002) 69K

Penicillin Allergy: Asking the Important Questions by Donna Mabe, Pharm.D.

New Director of Pharmacy Operations Appointed at UWMC

P & T Committee Actions, December '01

Supplements

Vol. 31 No. 1 Table of Contents
82: Vol. 30 No. 8 (2001) 42K

Welcome, New House Staff

Rx with Care (Revised from an original article by J. Ann Napierkowski, R.Ph.)

From the Institute for Safe Medication Practices: Safe Practice Recommendations

UWMC/HMC Prescription Essentials

Important Points to Remember about Prescriptions

2001-2002 Drug Formulary Published

P & T Committee Actions, July '01

Supplements

Vol. 30 No. 8 Table of Contents
83: Vol. 30 No. 7 (2001) 32K

Drug Shortages: Information Exchange is Key

Tetanus Toxoid Shortage

P & T Committee Actions, June '01

Supplements

Vol. 30 No. 7 Table of Contents
84: Vol. 30 No. 6 (2001) 34K

Rare But Important ADRs: Histamine H2-Receptor Antagonist-Induced Nephrotoxicity and Hepatotoxicity (by Elizabeth Rudy D.V.M., R.Ph.)

UWMC/HMC Adverse Drug Reaction Summary

Some Dangerous Abbreviations to Avoid

Supplements

Vol. 30 No. 6 Table of Contents
85: Vol. 30 No. 5 (2001) 49k

Irritable Bowel Syndrome: Life Beyond Alosetron (by Heidi S. Wirtz, Pharm.D.)

P & T Committee Actions, April '01 

Supplements

Vol. 30 No. 5 Table of Contents
86: Vol. 30 No. 4 (2001) 62k

Health Care Practitioners and Adverse Drug Reactions: Why Are They Underreported? (by Elizabeth Rudy, D.V.M., R.Ph.)

UWMC/HMC Adverse Drug Reaction Summary

Adverse Drug Reaction Reporting: A Collaborative Duty (by Jamie L. Daugherty, Pharm.D.)

P & T Committee Actions, March '01 

Supplements

Vol. 30 No. 4 Table of Contents
87: Vol. 30 No. 3 (2001) 38k

Is It Ever Too Late to Discover the True Toxicity of a Drug? (by Michael J. Wong, Pharm.D.)

P & T Committee Actions, February '01

Supplements

Vol 30. No. 3 Table of Contents
88: Vol. 30 No. 1-2 (2001) 41K

When Business and Practice Collide: Direct-to-Consumer Advertising (by Michelle Moomaw, Pharm.D.)

One-Stop Shopping for Health Information on the Internet: MEDLINEplus

P & T Committee Actions, January '01

Supplements

Vol. 30 No. 1 Table of Contents
Vol. 30 No. 2 Table of Contents
89: Vol. 30 No. 12 (2001) 48K

Anthrax: Steps Toward Evolution of the Best Treatment Dana A. Stieber, Pharm.D.

Two Successful Anthrax Outcomes Reported Following High-dose Ciprofloxacin/Rifampin/ Clindamycin Regimen

P & T Committee Actions, November '01

Supplements

Vol. 30 No. 12 Table of Contents
90: Vol. 30 No. 10 (2001) 38K

2001 Influenza Vaccination Update

CDC Letter Regarding Influenza Vaccinations

Recommendations For Influenza Vaccination

Influenza FAQ

P&T Committee Actions, September '01

Supplements

Vol.30 No.10 Table of Contents
91: Vol. 29 No. 9 (2000) 67K

HIV Postexposure Prophylaxis for Health-Care Workers (by Denise Cummings, Pharm.D.)

Anaphylactic Reactions Associated with Neuromuscular Blocking Agents (by Elizabeth Rudy, D.V.M., R.Ph.)

UWMC/HMC Adverse Drug Reaction Summary

P & T Committee Actions, August '00

NorplantŪ Advisory Update

Clarification, Vol. 29 No. 7: Optimal Properties of Agents Used to Treat Acute, Uncomplicated Urinary Tract Infections

Errata, 2000/2001 Drug Formulary: Page 248 and 367

Supplements

Bibliography-NMB Table of Contents
Bibliography-PEP Table of Contents
Vol. 29 No. 9 Table of Contents
92: Vol. 29 No. 8 (2000) 41K

Iron, EPO, and Cancer: A Conservative Approach (by Heather L. Davis, Pharm.D.)

Supplements

Bibliography Table of Contents
Vol. 29 No. 8 Table of Contents
93: Vol. 29 No. 7 (2000) 62K

Optimal Properties of Agents Used to Treat Acute, Uncomplicated Urinary Tract Infections (by Julie Garrison, Pharm.D.)

Letter from ID Subcommittee to Medical Staff Regarding Linezolid

Percocet(R) Reminder: Strength Required on Prescriptions

P & T Committee Actions, June '00 

Supplements

Bibliography Table of Contents
Vol. 29 No. 7 Table of Contents
94: Vol. 29 No. 6 (2000) 98K

Use of Anticonvulsants for Painful Neuropathy (by Megan McMurray, Pharm.D.)

Potential for Adverse Drug Events: St. John's Wort-Associated Drug Interactions (by Elizabeth Rudy, D.V.M., R.Ph.)

UWMC/HMC Adverse Drug Reaction Summary

Supplements

Bibliography Table of Contents
Vol. 29 No. 6 Table of Contents
95: Vol. 29 No. 4-5 (2000) 40K

University of Washington/Harborview Medical Center Adopt Medical Marijuana Policy (by Jennifer Brzana, Pharm.D.)

Milo Gibaldi Honored at World Congress as "Millennial Pharmaceutical Scientist"

P & T Committee Actions, Mar.-Apr., '00

Supplements

Vol. 29 No. 4 Table of Contents
Vol. 29 No. 5 Table of Contents
96: Vol. 29 No. 3 (2000) 63K

Emergency Contraceptive Pills: It's Not Too Late (by Michael L. Lim, Pharm. D.)

Ketorolac Use in the Breast-feeding Woman: Potential for Adverse Drug Reactions in the Nursing Infant? (by Elizabeth Rudy, D.V.M., R.Ph.)

UWMC/HMC Adverse Drug Reaction Summary

P & T Committee Actions, February '00

Supplements

Bibliography Table of Contents
Vol. 29 No. 3 Table of Contents
97: Vol. 29 No. 1-2 (2000) 86K

The Glitazones: Proceed With Caution (by Daniel Krische, Pharm.D.)

Focus on Process Improvement: Anticoagulant Therapy Management

Index to 1999 Drug Therapy TopicsFeature Articles

Summary of 1999 Pharmacy & Therapeutics Committee Drug Formulary Actions

P & T Committee Actions, January '99

Supplements

Vol. 29 No. 1 Table of Contents
Vol. 29 No. 2 Table of Contents
98: Vol. 29 No. 12 (2000) 75K

Selective COX-2 Inhibitors: Selective Enough to Avoid Toxicities? (by Amy J. Hatfield, Pharm.D.)

UWMC/HMC Adverse Drug Reaction Summary

Flu Vaccine Update

P & T Committee Actions, November '00

Supplements

Vol. 29 No. 12 Table of Contents
99: Vol. 29 No. 10-11 (2000) 93K

Delays in Influenza Vaccine Supply--The Question of Neuraminidase Inhibitors (by Henry Wong, Pharm.D.)

Lepirudin for Anticoagulation in Heparin-Induced Thrombocytopenia (by L. Midori Kondo, Pharm.D.)

P & T Committee Actions, Sept. and Oct. '00

Supplements

Vol. 29 No. 10 Table of Contents
Vol. 29 No. 11 Table of Contents
100: Vol. 28 No. 9 (1999) 34K

Assessment of Vancomycin Use at UWMC/HMC (Extracted from a Drug Utilization Evaluation by George P. Allen, Pharm.D.)

Guidelines for Prudent (Appropriate) Vancomycin Use

Focus on Process Improvement: Sedation Associated with Mechanical Ventilation in the ICU at UWMC)

New 1999/2000 UWMC/HMC/UWP Network Clinic Drug Formularies Distributed

P & T Committee Actions, August '99

Supplements

Vol. 28 No. 9 Table of Contents
Next Page -->






Terms of Use and Disclaimer
Website Comments/Questions